Trademarkia Logo

Canada

C$
Trademark Search in Canada
KRINGLE PHARMA

View On IC.GC.CA

KRINGLE PHARMA
REGISTERED

on 28 Jun 2024

Last Applicant/ Owned by

KRINGLE PHARMA INC.

2F Saito Bio Incubator,7-7-15, Saitoasagi,Ibaraki-shiOsaka 567-0085

JP

Serial Number

2135513 filed on 5th Aug 2021

Registration Number

TMA1240969 registered on 28th Jun 2024

Registration expiry Date

2th Sept 2033

Correspondent Address

MARKS & CLERK

33 Yonge Street, Suite 300Toronto

ONTARIO

CA

M5E1G4

KRINGLE PHARMA

Trademark usage description

pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the prevention and treatment of renal d Read More

Classification Information

Class [005]
Pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the prevention and treatment of renal disease and disorders; pharmaceutical preparations for the treatment of central nervous system diseases; pharmaceutical preparations for use in dermatology, namely dermatitis, skin pigmentation diseases and treatment of acne; pharmaceutical preparations for the treatment of cardiovascular diseases; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations, namely, stimulants for the central nervous system, hair growth stimulants, antipyretic analgesics, anti-epileptic pharmaceutical preparations, hypnotic sedatives, general anesthetics, anti-motion sickness agents; pharmaceutical preparations acting on the peripheral nervous system for treating solitary peripheral neuritis, polyneuritis monopoly, polyneuritis, radial nerve palsy, median nerve palsy, ulnar nerve palsy, peroneal nerve palsy, tibial nerve palsy, facial palsy, Bell palsy, oppressive neuropathy, acute intermittent porphyria, chronic inflammatory demyelinating neuropathy, trigeminal neuralgia, diabetic neuropathy, vitamin B deficiency, pellagra, beriberi, polyarthritis nodosa, systemic lupus erythematosus, carpal tunnel syndrome, tarsal tunnel syndrome, elbow tunnel syndrome, back pain, allodynia, pain of finger, numbness of finger, Guillain-Barre syndrome, Charcot-Marie-Tooth disease, Familial amyloid polyneuropathy, Addictive neuropathy, cancer neuropathy, Crow-Fukase syndrome, Postherpetic neuralgia, Polyneuropathy, Polyradiculitis, Neronopathy, Mononeuropathy, Multiple mononeuropathy, Plexopathy; pharmaceutical preparations, namely, local anesthetics, skeletal muscle relaxants, anhidrotics, autonomics in the nature of pharmaceutical preparations for treating heart conditions, antispasmodics, diaphoretics; pharmaceutical preparations for the prevention and treatment of ophthalmic diseases; pharmaceutical preparations, namely, nasal spray preparations, eye drops, eye washes; pharmaceutical preparations for the treatment of eye infections, macular degeneration, glaucoma, allergic rhinitis, and chronic rhino sinusitis; pharmaceutical preparations, namely, antiallergic agents, antihistamines; pharmaceutical preparations for the treatment of cardiovascular disease; pharmaceutical preparations, namely, cardiotonics, antihypertensives, vasoconstrictors; capillary stabilizers, namely, pharmaceutical preparations for stabilizing capillaries; pharmaceutical preparations, namely, cerebral hemorrhage prophylactic agents, antiarrhythmic agents, diuretics; pharmaceutical preparations for the prevention and treatment of disorders of the respiratory system; pharmaceutical preparations, namely, respiratory stimulants, anti-cough drops, antitussive expectorants; pharmaceutical preparations acting on digestive organs for treating ulcers and digestive conditions; pharmaceutical preparations, namely, gastrointestinal cleaning agents; pharmaceutical preparations clysters in the nature of enema preparations; pharmaceutical preparations, namely, evacuants (purgatives); pharmaceutical preparations for the treatment of gastroenterological, intestine, bowel, stomach and digestive disorders; pharmaceutical preparations for the treatment of dental and oral disease; pharmaceutical preparations, namely, emetics, antacids; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; pharmaceutical preparations, namely, antiemetics, castor oil for medical purposes, cholagogues, hormones for medical purposes, thyroid and para-thyroid hormone preparations, mixed hormone preparations, estrogen preparations, pancreas hormone preparations, salivary gland hormone preparations, androgen preparations, pituitary hormone preparations, adrenal hormone preparations, oxytocics, anti-hemorrhoidals, emmenagogues; oral contraceptives, injectable pharmaceutical contraceptives; medicated skin care preparations for treating, reducing, and preventing lines, pores, and loss of skin firmness; medicated skin care preparations for use as a moisturizer and a skin cleanser; pharmaceutical preparations for treating purulence wound; pharmaceutical preparations, namely, anti-dermoinfectives; antimicrobials for dermatologic use, astringents for medical purposes, anti-inflammatory agents, analgesics, anti-itching pharmaceutical preparations, talcum powder used for absorbing moisture, hair growth preparations, medicated baby oils for dermatologic use, medicated baby powders, medicated bath preparations for the treatment of irritated, itching and inflamed skin; pharmaceutical preparations, namely, vitamin preparations, codliver oil drops, mixed vitamin preparations, vitamin A preparations, vitamin C preparations, vitamin D preparations, vitamin B preparations, multi-vitamin preparations, amino acid preparations, threonine preparations, tryptophane preparations, methionine preparations, lysine preparations, royal jelly for medical purposes, calcium pharmaceutical preparations, chondroitin preparations; pharmaceutical preparations namely, protein supplements and amino acid dietary supplements; pharmaceutical preparations, namely, saccharide preparations for treating skin diseases, namely, skin ulcer, injury, burn, scleroderma, dermatitis, erythroderma, keratosis, dyschromatopsia, and lupus erythematosus; pharmaceutical preparations, namely, mineral preparations; pharmaceutical preparations, namely, anticoagulants, blood substitutes, blood plasma, haemostatics for medical purposes; pharmaceutical preparations for the prevention and treatment of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; pharmaceutical preparations, namely, antidotes, digestive enzymes used to treat pancreatic disease for medical purposes, lactagogues, lipotropic factor preparations; pharmaceutical preparations for the treatment of drug and alcohol abuse; pharmaceutical preparations, namely, tumor suppressing agents, anti-cancer preparations, anti-sarcoma preparations, agents for treating physically caused lesions, heatstroke treating agents; pharmaceutical preparations for treating the symptoms of radiation sickness; pharmaceutical preparations for treating chemically caused disorders, namely, for treating chemical burns, side effects of anticancer drugs, and side effects of immunosuppressants; pharmaceutical preparations, namely, chlorine detoxication agents, arsenic-detoxication agents, benzol-detoxication agents, antibiotic preparations, erythromycin preparations, chloramphenicol preparations; antibiotic preparations namely, colistin-polymyxin and capreomycin, streptomycin preparations, thiolutin preparations, tetracycline preparations, trichomycin preparations, mixed antibiotic preparations, penicillin preparations, chemotherapeutics, antisyphilitics, antituberculous preparations, sulfonamide preparations, antileprotic agents; pharmaceutical preparations, namely, biological preparations for medical purposes, namely, biological tissue grafts; pharmaceutical preparations, namely, antitoxic sera, antitoxins; pharmaceutical and biological preparations for medical use, namely, for the prevention and treatment of cancer; pharmaceutical preparations, namely, preparations for biological tests for medical purposes, namely, medical diagnostic reagents for testing of body fluids; pharmaceutical preparations, namely, toxoids, namely, vaccines against the flu; pharmaceutical preparations, namely, human vaccines, preparations for destroying parasites, anthelmintics, odor neutralizing preparations for use on hard surfaces that have had contact with odorous pharmaceuticals, diagnostic reagents and agents for medical diagnostic use, x-ray contrast agents; pharmaceutical preparations, namely, diagnostic media for bacteriological cultures; pharmaceutical preparations, namely, radio-isotope markers for therapeutic and diagnostic use, opium alkaloid preparations, synthetic narcotics, coca alkaloid preparations for medical purposes, acidifiers to increase levels of gastric acid to decrease stomach pH for veterinary purposes, anti-inflammatories, and cardiovascular agents for veterinary use, mosquito-repellent incenses, insecticides, fungicides, herbicides, pesticides, rodenticides, insect-repellents, germicides and fungicides, antiseptics.

Classification kind code

10

Class [042]
Testing, inspection or research of pharmaceuticals and genetics; medical research; consultancy and providing information services relating to testing, inspection or research of pharmaceuticals and genetics; consultancy and providing information services relating to medical research.

Classification kind code

10

Mark Details

Serial Number

2135513

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 238
on 2th Sept 2023		IR Renewed
Submitted for opposition 22
on 5th Jan 2023		Search Recorded
Submitted for opposition 20
on 5th Jan 2023		Examiner's First Report
Submitted for opposition 223
on 5th Jan 2023		Total Provisional Refusal
Submitted for opposition 256
on 25th Jul 2022		Notification of Possible Opposition Sent
Submitted for opposition 257
on 23rd Sept 2021		Designation Notification - Madrid Protocol
Submitted for opposition 1
on 23rd Sept 2021		Created
Submitted for opposition 31
on 23rd Sept 2021		Formalized
Submitted for opposition 30
on 5th Aug 2021		Filed
Submitted for opposition 228
on 2th Sept 2013		International Registration